BioVie Statistics
Total Valuation
BioVie has a market cap or net worth of $8.58 million. The enterprise value is $1.10 million.
Important Dates
The last earnings date was Friday, November 6, 2026, after market close.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioVie has 10.72 million shares outstanding. The number of shares has increased by 205.60% in one year.
| Current Share Class | 10.72M |
| Shares Outstanding | 10.72M |
| Shares Change (YoY) | +205.60% |
| Shares Change (QoQ) | +4.35% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 16.60% |
| Float | 10.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.21 |
| P/TBV Ratio | 1.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.04.
| Current Ratio | 2.40 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,363.57 |
Financial Efficiency
Return on equity (ROE) is -143.66% and return on invested capital (ROIC) is -89.81%.
| Return on Equity (ROE) | -143.66% |
| Return on Assets (ROA) | -76.00% |
| Return on Invested Capital (ROIC) | -89.81% |
| Return on Capital Employed (ROCE) | -344.18% |
| Weighted Average Cost of Capital (WACC) | 8.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.74M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.61% in the last 52 weeks. The beta is 0.80, so BioVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -41.61% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 1.52 |
| Relative Strength Index (RSI) | 30.51 |
| Average Volume (20 Days) | 917,538 |
Short Selling Information
The latest short interest is 589,058, so 5.49% of the outstanding shares have been sold short.
| Short Interest | 589,058 |
| Short Previous Month | 544,444 |
| Short % of Shares Out | 5.49% |
| Short % of Float | 5.52% |
| Short Ratio (days to cover) | 3.27 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -23.02M |
| Pretax Income | -22.59M |
| Net Income | -22.59M |
| EBITDA | -22.85M |
| EBIT | -23.02M |
| Earnings Per Share (EPS) | -$2.82 |
Full Income Statement Balance Sheet
The company has $7.73 million in cash and $254,374 in debt, with a net cash position of $7.48 million or $0.70 per share.
| Cash & Cash Equivalents | 7.73M |
| Total Debt | 254,374 |
| Net Cash | 7.48M |
| Net Cash Per Share | $0.70 |
| Equity (Book Value) | 6.53M |
| Book Value Per Share | 0.75 |
| Working Capital | 6.10M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -18.91M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 165,582 |
| Net Borrowing | n/a |
| Free Cash Flow | -18.91M |
| FCF Per Share | -$1.76 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BioVie does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -205.60% |
| Shareholder Yield | -205.60% |
| Earnings Yield | -352.90% |
| FCF Yield | -224.63% |
Analyst Forecast
The average price target for BioVie is $5.26, which is 556.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.26 |
| Price Target Difference | 556.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 7, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |